Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2004 3
2005 2
2007 3
2008 8
2009 8
2010 8
2011 8
2012 8
2013 9
2014 8
2015 4
2016 4
2017 5
2018 4
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Pictet-Spengler condensations using 4-(2-aminoethyl)coumarins.
Sviripa VM, Fiandalo MV, Begley KL, Wyrebek P, Kril LM, Balia AG, Parkin SR, Subramanian V, Chen X, Williams AH, Zhan CG, Liu C, Mohler JL, Watt DS. Sviripa VM, et al. New J Chem. 2020 Aug 21;44(31):13415-13429. doi: 10.1039/d0nj02664f. Epub 2020 Jul 22. New J Chem. 2020. PMID: 33795928 Free PMC article.
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.
Venkadakrishnan VB, DePriest AD, Kumari S, Senapati D, Ben-Salem S, Su Y, Mudduluru G, Hu Q, Cortes E, Pop E, Mohler JL, Azabdaftari G, Attwood K, Shah RB, Jamieson C, Dehm SM, Magi-Galluzzi C, Klein E, Sharifi N, Liu S, Heemers HV. Venkadakrishnan VB, et al. Oncogene. 2019 Jun;38(23):4496-4511. doi: 10.1038/s41388-019-0732-7. Epub 2019 Feb 11. Oncogene. 2019. PMID: 30742064 Free PMC article.
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.
Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG. Li Q, et al. Nat Commun. 2018 Sep 6;9(1):3600. doi: 10.1038/s41467-018-06067-7. Nat Commun. 2018. PMID: 30190514 Free PMC article.
Lipid degradation promotes prostate cancer cell survival.
Itkonen HM, Brown M, Urbanucci A, Tredwell G, Ho Lau C, Barfeld S, Hart C, Guldvik IJ, Takhar M, Heemers HV, Erho N, Bloch K, Davicioni E, Derua R, Waelkens E, Mohler JL, Clarke N, Swinnen JV, Keun HC, Rekvig OP, Mills IG. Itkonen HM, et al. Oncotarget. 2017 Jun 13;8(24):38264-38275. doi: 10.18632/oncotarget.16123. Oncotarget. 2017. PMID: 28415728 Free PMC article.
A four gene signature predictive of recurrent prostate cancer.
Komisarof J, McCall M, Newman L, Bshara W, Mohler JL, Morrison C, Land H. Komisarof J, et al. Oncotarget. 2017 Jan 10;8(2):3430-3440. doi: 10.18632/oncotarget.13837. Oncotarget. 2017. PMID: 27966447 Free PMC article.
77 results